Lobbying disclosures · Lobbying report
DXCM: third_quarter 2026 lobbying report
Issues related to coverage and reimbursement for continuous glucose monitors. Issues related to coverage and reimbursement for continuous glucose monitors.
Follow DXCM- Became public
- Oct 20, 2026, 10:03 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 12:38 PM EST
Why this is connected
Exact legal-name match: DEXCOM INC (https://www.sec.gov/Archives/edgar/data/1093557/).
Reported lobbying amounts
Income: $40,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/80088a5b-c0da-40de-89a4-68f265476ca6/","filing_uuid":"80088a5b-c0da-40de-89a4-68f265476ca6","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/80088a5b-c0da-40de-89a4-68f265476ca6/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Adam J. Biegel","dt_posted":"2026-10-20T10:03:00-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"THE ATLANTIC BUILDING","registrant_address_2":"950 F STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1182,"url":"https://lda.gov/api/v1/registrants/1182/","house_registrant_id":31748,"name":"ALSTON & BIRD LLP","description":"Law Firm","address_1":"THE ATLANTIC BUILDING","address_2":"950 F STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM J. BIEGEL","contact_telephone":"+1 202-239-3692","dt_updated":"2026-07-20T16:02:02.800694-04:00"},"client":{"id":102538,"url":"https://lda.gov/api/v1/clients/102538/","client_id":1006827,"name":"DEXCOM, INC.","general_description":"Medical Device manufacturing.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-02"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to coverage and reimbursement for continuous glucose monitors.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40740,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"P","last_name":"TRYSLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65067,"prefix":null,"prefix_display":null,"first_name":"Y. BRIAN","nickname":null,"middle_name":null,"last_name":"LEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102877,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"PATRICK","last_name":"PALUSKIEWICZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to coverage and reimbursement for continuous glucose monitors.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40740,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"P","last_name":"TRYSLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65067,"prefix":null,"prefix_display":null,"first_name":"Y. BRIAN","nickname":null,"middle_name":null,"last_name":"LEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102877,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"PATRICK","last_name":"PALUSKIEWICZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in DXCM
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- May 10, 2026$100K–$250K
Sen. Tina Smith (D-MN)
$100K–$250K · Traded May 7, 2026 · disclosed May 10, 2026 · Spouse
- May 10, 2026$100K–$250K
Sen. Tina Smith (D-MN)
$100K–$250K · Traded Apr 29, 2026 · disclosed May 10, 2026 · Spouse
- Feb 15, 2026$1K–$15K
Sen. John Boozman (R-AR)
$1K–$15K · Traded Jan 26, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 8, 2025 · disclosed Jun 22, 2025
- Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed Jun 9, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.